Fitzpatrick Case Update
March 20, 2012
On March 20, 2012, the U.S. Supreme Court issued a unanimous (9-0) opinion in Mayo Collaborative Services v. Prometheus Laboratories, Inc., concerning the scope of patent-eligible subject matter. The Court reversed the Federal Circuit and held that Prometheus’s process for optimizing dosage was a law of nature and thus unpatentable under 35 U.S.C. § 101.